Intravenous Home Infusion Therapy Instituted From a 24-Hour Clinical Decision Unit Decreases Hospitalization for Patients With Cellulitis

被引:0
|
作者
Andrews, S.
Rivera, S.
Baner, N.
Goltser, Y.
Wu, M.
Chen, A.
Tomassetti, D.
Silverman, R.
Ward, M. F.
Rentala, M.
机构
[1] Long Isl Jewish Med Ctr, New Hyde Pk, NY 11042 USA
[2] N Shore Univ Hosp, Manhasset, NY USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:S50 / S50
页数:1
相关论文
共 35 条
  • [1] Intravenous Home Infusion Therapy Instituted From a 24-Hour Clinical Decision Unit For Patients With Cellulitis
    Rentala, Manjusha
    Andrews, Shari
    Tiberio, Allison
    Alagappan, Kumar
    Tavdy, Tammy
    Sheppard, Patrick
    Silverman, Robert
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (07): : 1273 - 1275
  • [2] Predictive Variables Associated With Observation Failures in a 24-hour Clinical Decision Unit
    Loftus, A.
    Rosen, L.
    Mounessa, J.
    Polak, G.
    Asia-Bose, R.
    Persky, A.
    Mongone, J.
    Alagappan, K.
    Ward, M. F.
    Rentala, M.
    ANNALS OF EMERGENCY MEDICINE, 2012, 60 (04) : S97 - S98
  • [3] Predictive Variables Associated With Inappropriate Length of Stay in a 24-hour Clinical Decision Unit
    Loftus, A.
    Polak, G.
    Rosen, L.
    Lawrence, E.
    Chacko, L.
    Arestehmanesh, D.
    Fay, B.
    Alagappan, K.
    Ward, M.
    Rentala, M.
    ANNALS OF EMERGENCY MEDICINE, 2012, 60 (04) : S5 - S5
  • [4] Clinical and pharmacokinetic phase I study with Cematodin(R) given as continuous 24-hour intravenous infusion
    Mross, K
    Fiebig, HH
    Berdel, W
    Bankmann, Y
    vonBroen, IM
    Walter, N
    Unger, C
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1122 - 1122
  • [5] A PHASE-I TRIAL OF BRYOSTATIN 1 IN PATIENTS WITH ADVANCED MALIGNANCY USING A 24-HOUR INTRAVENOUS-INFUSION
    JAYSON, GC
    CROWTHER, D
    PRENDIVILLE, J
    MCGOWN, AT
    SCHEID, C
    STERN, P
    YOUNG, R
    BRENCHLEY, P
    CHANG, J
    OWENS, S
    PETTIT, GR
    BRITISH JOURNAL OF CANCER, 1995, 72 (02) : 461 - 468
  • [6] EFFECT OF INTRAVENOUS-INFUSION OF OMEPRAZOLE AND RANITIDINE ON 24-HOUR INTRAGASTRIC PH IN PATIENTS WITH A HISTORY OF DUODENAL-ULCER
    KIILERICH, S
    RANNEM, T
    ELSBORG, L
    DIGESTION, 1995, 56 (01) : 25 - 30
  • [7] ASSESSMENT OF HEMODYNAMIC TOLERANCE FROM A 24-HOUR, INTRAVENOUS-INFUSION OF FENOLDOPAM MESYLATE IN CONGESTIVE HEART-FAILURE
    MUNGER, MA
    JARVIS, RC
    GREEN, JA
    NARA, AR
    POSPISIL, RA
    KASMER, RJ
    PHARMACOTHERAPY, 1988, 8 (02): : 119 - 119
  • [8] ASSESSMENT OF HEMODYNAMIC TOLERANCE FROM A 24-HOUR INTRAVENOUS-INFUSION OF FENOLDOPAM MESYLATE IN CONGESTIVE HEART-FAILURE
    MUNGER, MA
    BENOTTI, JR
    GREEN, JA
    JARVIS, RC
    NARA, AR
    MCCUE, JE
    POSPISIL, RA
    KASMER, RJ
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (03): : 206 - 210
  • [9] 2-Chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia
    Robak, T
    BlasinskaMorawiec, M
    Krykowski, E
    Hansz, J
    Komarnicki, M
    Kazimierczak, M
    Konopka, L
    Maj, S
    Hellmann, A
    Zaucha, JM
    Urasinski, L
    Zdziarska, B
    KotlarekHaus, S
    UsnarskaZubkiewicz, L
    Kuratowska, Z
    DwilewiczTrojaczek, J
    Holowiecki, J
    KrawczykKulis, M
    Grieb, P
    LEUKEMIA & LYMPHOMA, 1996, 22 (1-2) : 107 - 111
  • [10] A phase I Pharmacologic and pharmacodynamic study of pyrazoloacridine given as a weekly 24-hour continuous intravenous infusion in adult cancer patients
    Grem, JL
    Harold, N
    Keith, B
    Chen, AP
    Kao, V
    Takimoto, CH
    Hamilton, JM
    Pang, J
    Pace, M
    Jasser, GB
    Quinn, MG
    Monahan, BP
    CLINICAL CANCER RESEARCH, 2002, 8 (07) : 2149 - 2156